Learn About Multiple Endocrine Neoplasia Type 1

What is the definition of Multiple Endocrine Neoplasia Type 1?

Multiple endocrine neoplasia (MEN) type I is a disease in which one or more of the endocrine glands are overactive or forms a tumor. It is passed down through families.

Endocrine glands most commonly involved include:

  • Pancreas
  • Parathyroid
  • Pituitary
Save information for later
Sign Up
What are the alternative names for Multiple Endocrine Neoplasia Type 1?

Wermer syndrome; MEN I

What are the causes of Multiple Endocrine Neoplasia Type 1?

MEN I is caused by a defect in a gene that carries the code for a protein called menin. The condition causes tumors of various glands to appear in the same person, but not necessarily at the same time.

The disorder may occur at any age, and it affects men and women equally. A family history of this disorder raises your risk.

What are the symptoms of Multiple Endocrine Neoplasia Type 1?

Symptoms vary from person to person, and depend on which gland is involved. They may include:

  • Abdominal pain
  • Anxiety
  • Black, tarry stools
  • Bloated feeling after meals
  • Burning, aching, or hunger discomfort in the upper abdomen or lower chest that is relieved by antacids, milk, or food
  • Decreased sexual interest
  • Fatigue
  • Headache
  • Lack of menstrual periods (in women)
  • Loss of appetite
  • Loss of body or facial hair (in men)
  • Mental changes or confusion
  • Muscle pain
  • Nausea and vomiting
  • Sensitivity to the cold
  • Unintentional weight loss
  • Vision problems
  • Weakness
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Multiple Endocrine Neoplasia Type 1?

Surgery to remove the diseased gland is often the treatment of choice. A medicine called bromocriptine may be used instead of surgery for pituitary tumors that release the hormone prolactin.

The parathyroid glands, which control calcium production, can be removed. However, it is difficult for the body to regulate calcium levels without these glands, so a total parathyroid removal is not done first in most cases.

Medicine is available to decrease the excess stomach acid production caused by some tumors (gastrinomas), and to reduce the risk of ulcers.

Hormone replacement therapy is given when entire glands are removed or do not produce enough hormones.

Who are the top Multiple Endocrine Neoplasia Type 1 Local Doctors?
Elite
Distinguished
 
 
 
 
Learn about our expert tiers
Learn more
Advanced
What is the outlook (prognosis) for Multiple Endocrine Neoplasia Type 1?

Pituitary and parathyroid tumors are usually noncancerous (benign), but some pancreatic tumors may become cancerous (malignant) and spread to the liver. These can lower life expectancy.

The symptoms of peptic ulcer disease, low blood sugar, excess calcium in the blood, and pituitary dysfunction usually respond well to appropriate treatment.

What are the possible complications of Multiple Endocrine Neoplasia Type 1?

The tumors can keep coming back. Symptoms and complications depend on which glands are involved. Regular check-ups by your provider are essential.

When should I contact a medical professional for Multiple Endocrine Neoplasia Type 1?

Contact your provider if you notice symptoms of MEN I or have a family history of this condition.

How do I prevent Multiple Endocrine Neoplasia Type 1?

Screening close relatives of people affected with this disorder is recommended.

Endocrine glands
What are the latest Multiple Endocrine Neoplasia Type 1 Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
What are the Latest Advances for Multiple Endocrine Neoplasia Type 1?
Tired of the same old research?
Check Latest Advances
Who are the sources who wrote this article ?

Published Date: January 25, 2022
Published By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

National Comprehensive Cancer Network website. Clinical practice guidelines in oncology (NCCN guidelines): neuroendocrine and adrenal tumors. Version 1.2022. www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf. Updated May 23, 2022. Accessed August 23, 2022.

Newey PJ, Thakker RV. Multiple endocrine neoplasia. In: Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rosen CJ, eds. Williams Textbook of Endocrinology. 14th ed. Philadelphia, PA: Elsevier; 2020:chap 42.

Nieman LK, Spiegel AM. Polyglandular disorders. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 218.

Thakker RV. Multiple endocrine neoplasia type 1. In: Jameson JL, De Groot LJ, de Kretser DM, et al, eds. Endocrinology: Adult and Pediatric. 7th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 148.